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Abstract
Neonatal sepsis in the developing world is incompletely characterized. We seek to characterize the microbial spectrum
involved in sepsis and determine the role of maternal transmission by comparing organisms that can be cultured from
septic newborn infants and their mothers. From 80 consecutive mother-infant pairs meeting clinical criteria for neonatal
sepsis, we collected infant blood and spinal fluid, and maternal blood and vaginal specimens. Identifiable bacteria were
recovered from the blood in 32.5% of infants, and from 2.5% of cerebrospinal fluid cultures, for a total of 35% recoverable
putative causative agents. Bacteria recovered from vaginal specimens were not concordant with those recovered from
infants. Similarly there was no concordance of bacteria recovered from blood and cerebrospinal fluid. We conclude that
relying on traditional bacterial culture techniques does not adequately delineate the role of maternal versus environmental
sources of neonatal sepsis in this setting. More sensitive molecular approaches will be needed to properly characterize the
maternal and environmental microbial community involved in neonatal sepsis in such developing countries.
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Background
Neonatal sepsis (NS), a severe systemic bacterial infection in
newborn infants within the first 4 weeks of life, claims over 1.5
million infant lives each year, the majority in sub-Saharan Africa
and southern Asia [1]. There are two classes of NS: early onset,
within the first week of life presumed to be acquired from prenatal
and intrapartum maternal transmission, and late onset within
weeks 2–4 of life from environmental and nosocomial sources [1].
The spectrum of bacteria causing NS in industrialized countries
is relatively homogenous in North America, Europe, Australia,
and South Africa: group B Streptococcus, Escherichia coli, and Listeria
monocytogenes dominate [2]. When gram-negative enteric bacteria
cause NS in industrialized countries, risk factors typically include
neural tube defects and urinary tract anomalies [3]. In contrast,
the spectrum of bacteria causing NS in the developing world can
be biased towards Gram negative organisms, and particular
bacterial spectra can differ from each site where high quality
(culture positive) data are available [4,5]. There can be a striking
rarity of group B Streptococcus (GBS) in many studies in the
developing world [6,7], and maternal carriage rates of this
organism appear to differ at various sites [7,8,9]. Nevertheless,
where GBS is the most common organism isolated in NS [10,11],
maternal carriage rates are comparable to those in industrialized
countries [12]. Such conflicting findings have hampered our
understanding of prevention and treatment of neonatal sepsis in
the developing world.
Long-term, we seek to define the neonatal septisome – the sum total
of the invasive microorganisms that are found within septic
newborn infants. Such a broad microbial characterization goes
beyond the typical assumption of single species bacterial causality
of the syndrome of NS in an individual patient, and admits the
possibility that NS could arise from a polymicrobial infection
including both bacteria and viruses. Our broad characterization is
in part motivated by the difficulties in identifying the underlying
etiology of postinfectious hydrocephalus, which occurs as a sequela
in a subset of survivors of NS [13].
In this report, we focus on traditional bacteriological culture
techniques to assess samples from infants with NS and their
mothers at the Mbarara Regional Hospital in Uganda. We
correlated organisms recovered from infant blood and cerebrosp-
inal fluid (CSF), in addition to maternal vaginal flora, in order to
seek a more comprehensive characterization of the microbiological
spectrum and the role of maternal transmission in NS in this
setting.
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Ethics Statement: Under Institutional Review Board approval
from the Mbarara University of Science and Technology, Harvard
University, and Penn State University, the following study was
performed. Written consent was offered in both English (the
primary national language of Uganda), and Runyankore (the
regional language of southwestern Uganda). Written informed
consent was obtained from all participants. Further oversight for
this project was provided by the Uganda National Council for
Science and Technology.
The Mbarara Regional Referral Hospital is the main teaching
hospital for, and is situated adjacent to, the campus of the
Mbarara University of Science and Technology. It is the referral
center for southwestern Uganda, and typically admits several
hundred cases of presumed NS each year to its pediatric wards.
Eligibility was sought from neonates whose mothers were at
least 18 years of age and who met the following inclusion criteria:
1) Infant with presumed bacterial sepsis with either 1a) fever,
lethargy, and poor feeding, or 1b) hypothermia, lethargy, and poor
feeding, or 1c) fever, full fontanel, and poor feeding, 2) Infant
greater than 2.0 kg weight, and 3) Infant 1 month or less in age.
Exclusion criteria were 1) known local infection other than sepsis,
2) known congenital malformation, 3) known cutaneous or
gastrointestinal fistula, or 4) known birth trauma such as wounds
or fractures. We used these relatively strict clinical criteria to
maximize our yield of sick neonates who were likely to have true
microbiological sepsis.
Maternal interviews were conducted in a private examination
room off of the pediatrics ward dedicated to the maternal
interview and specimen collection. We permitted mothers to
withhold consent for having their vaginal samples collected, but
permitted their infants to be studied, if that was their personal
preference.
Following maternal informed consent, the following samples
were collected. Lumbar punctures were performed with sterile
disposable styletted neonatal spinal needles using aseptic techni-
que, withdrawing up to 0.6 mL of CSF allocated for culture and
gram stain (0.2 mL), for bacterial DNA (0.2 mL), and for viral
RNA (0.2 mL). DNA and RNA specimens were collected for
sequence analysis to be conducted in the future. CSF was only
withdrawn as free flow from the spinal needle within 1 minute
after insertion without suction, and only so long as free flow was
obtained.
Blood for all required tests was collected using standard aseptic
technique; withdrawing up to 1.0 mL blood, of which 0.4 mL was
allocated for culture, malaria smear, and HIV testing, followed by
0.2 mL for bacterial DNA, and 0.4 mL for viral RNA.
CSF and blood samples were taken immediately (within 2 hr)
upon admission, and prior to antibiotic administration. However,
some neonates referred in from a community clinic/health center
had received antibiotics prior to referral (31 of 80, 38.7%). No
infants were directly admitted from in-hospital delivery settings,
and none had an indwelling catheter prior to samples being taken.
Brain heart infusion broth contained in a universal bottle was
used as the primary medium for blood cultures, incubated at 35–
37uC and observed for bacterial growth after 24 hours, 48 hours,
and 72 hours for up to 7 days. For those bottles that indicated
evidence of bacterial growth (such as turbidity or hemolysis), Gram
stain was performed and subcultures plated onto solid media that
included blood agar, MacConkey agar and chocolate agar. The
chocolate agar plates were also incubated under increased CO2
atmosphere using a candle jar to enhance growth of fastidious
organisms.
CSF specimens were processed for cell counts, protein and
glucose determinations, Gram stain, India ink stain, culture and
sensitivity tests. Vaginal specimens were collected with sterile
swabs, and Gram stain, culture and sensitivity testing performed.
Culture media consisted of plates containing blood agar,
MacConkey agar and chocolate agar for both CSF and vaginal
specimens, and were incubated at 35–37uC for 48 hours.
Organisms were identified using morphology and staining,
culture characteristics on different media plus relevant available
conventional biochemical tests as follows:
1. Streptococci
For all suspected streptococci a Gram stain and catalase test
were performed. For suspected S. pneumoniae, the optochin
sensitivity test was performed. Facilities for the bile solubility test
were not available. Only inhibition zones of 9 mm and above were
considered positive. Discs for bacitracin to identify Group A
Streptococci represented by S. pyogenes were not available. Strepto-
cocci were expected to be catalase negative.
2. Staphylococci
The coagulase test for detecting free and bound coagulase was
performed to distinguish less pathogenic staphylococcus (S.
epidermidis) from the more pathogenic staphylococcus (S. aureus).
S. aureus gives a positive coagulase test. The catalase and DNAase
tests were also performed. All staphylococci give a positive catalase
test, and more than 50% of the coagulase positive S. aureus are also
DNAase positive. Although coagulase negative staphylococcus can
be an important pathogen in neonates [14], our blood cultures
were performed on a population of infants without indwelling
catheters or other foreign bodies rendering this organism an
unlikely pathogen.
3. Gram-negative bacteria
The following tests were performed for this group of bacteria:
indole, citrate utilization, urease, motility using the hanging drop
method, lactose/non-lactose fermentation on MacConkey agar,
oxidase test, and Kligler iron agar. The indole, urease, motility
and citrate utilization tests are especially important for differ-
entiating Klebsiella and E.coli.
Sensitivity testing was performed with Stokes’ method [15].
Maternal blood was tested for HIV using the Ugandan
nationally approved algorithm. The DetermineH HIV 1/2/O
rapid antibody test kit (Inverness Medical Japan Co.) was used as
the screening test, and all positive results were confirmed using the
STAT-PAKH test (Chembio Diagnostic Systems, Inc. NY, USA).
Discrepant results were resolved using a tie-breaker test – Uni-
GoldH HIV (Trinity Biotech plc, Bray, Ireland), and if positive,
CD4 counts were performed by flow cytometry using a BD-
FACSCaliburH instrument (Becton Dickinson, Franklin Lakes, NJ,
USA).
Results
Eighty consecutive mother-infant pairs (80 infants of 78 mothers
– including two sets of twins) were recruited from March through
November 2010. Sixty-five (81.3%) were classified as early-onset
sepsis (EOS), and 19 (23.7%) late-onset sepsis (LOS), by whether
their infections were manifest during or after the first week of life
respectively.
Blood cultures were positive in 26/80 neonates (32.5%). These
included 19 with EOS and 7 with LOS, and are summarized in
Table 1. We further stratified the EOS cases into ,24 hrs, 24–
48 hrs, and 2–6 days, using temporal stratification within the first
Microbial Spectrum of Neonatal Sepsis in Uganda
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organism recovered was S. aureus (20%), followed by E. coli (5%),
and Klebsiella sp. (2.5%); there was one group B Streptococcus
identified (1.25%). In 3 cases, Gram negative rods were recovered
which were unidentifiable (3.75%).
If we exclude the 31 neonates with antibiotic exposure we would
be left with 49 infants, 19 (39%) of whom were culture positive,
compared to 7 (23%) of the 31 with antibiotic exposure who were
culture positive. The odds ratio is 0.46, with a 95% confidence
interval of 0.17–1.28, that cultures are positive with prior
antibiotic exposure. Although proportionally more infants without
antibiotic exposure were culture positive, the relationship between
prior exposure to antibiotics and culture positivity was not
significant in this cohort.
Five infants were born to mothers known to be HIV positive
(either on self-report or testing) in this cohort; 3 of these (infants)
had S. aureus recovered from blood culture while the other 2 had
negative cultures. Maternal CD4 counts were available for 2 of the
3 infants with S. aureus growth 2442 and 705 cell/mL respectively.
The majority (67.5%) of infants meeting our clinical criteria for
sepsis did not demonstrate bacteria that we could recover through
blood culture. None of the blood culture-positive infants grew
more than a single organism.
CSF cultures were positive in 2/80 neonates (2.5%). There was
one isolate of S. pneumoniae, and one unidentified Gram-negative
rod. These isolates were both from patients without organisms
cultured from their blood.
The rate of recovery of pathogenic organisms associated with
NS from blood and CSF using these methods was 35% (28/80).
Vaginal specimens were positive for potential pathogens in 25/
53 mothers who consented to the collection procedure (47%,
taking into account that 2 vaginal specimens were mothers of twins
where both twins met our criteria for presumed sepsis). The most
common organisms recovered (Table 2) were Klebsiella species
(18.9%), followed by S. aureus (13.2%), E. coli (9.4%), C. albicans
(3.8%), one isolate of a Streptococcal species (1.9%) and an
unidentified Gram negative rod (1.9%).
The most common EOS organism recovered from the infant
blood, S. aureus, was a frequently identified pathogen on vaginal
culture, consistent with a maternal origin for some fraction of
infections with this particular organism. Nevertheless, when we
stratified maternal pathogens by the age of the onset of NS in cases
where neonatal blood cultures were positive, no clear linkage
pattern emerged (Table 3). Indeed, in 5 cases where we recovered
pathogenic bacteria both from maternal vaginal specimens and
infants’ blood culture, none of the organisms were concordant
(Table 4). In the two cases with positive CSF culture, one was from
a mother without recovery of pathogens from the vaginal
specimen, and one was from a mother that withheld consent for
a vaginal specimen.
Discussion
Neonatal sepsis is common in developing countries, but in the
studies of which we are aware, the putative causative agents are
often not identified from blood using bacterial culture. Our
recovery rate of pathogens in 32.5% of such infants is among the
higher percentages reported, and very similar to a comparable
study performed at the Mulago Hospital in Kampala where 37%
of infants had positive blood cultures [17], and to reports from
Nigeria [18] and India [19]. Our combined rate of organism
recovery from blood and CSF was 35%.
These rates of organism recovery were similar despite very
different blood volumes allocated for blood culture in the two
Ugandan series (0.4 vs 2.0 ml in ours vs the Mulago patients). We
constrained our volumes of blood obtained for culture by both
safety considerations in the structure of our proposal (1 ml total
blood was permitted), and our intention to broaden our testing of
blood specimens beyond bacterial culture (0.4 ml were allocated
for culture, malaria smear, and HIV testing). It is well established
that if the number of colony forming units per ml of blood
approaches small numbers, that the reliability of blood culture
decreases [20,21,22]. The tradeoff in the developing world is that
if the variety and breadth of the spectrum of fastidious or difficult
to culture organisms is increased, then molecular strategies [23]
may increase the identification rate. Below a certain number of
colony forming units per ml, small volume analysis will fail for all
techniques. But the similar rates of recovery, and the similar
spectrum of organisms in these two Ugandan series, suggests that
volume plays a considerably smaller role than the spectrum of the
Table 1. Blood culture summary.
Early-onset Late-onset Totals
,24 hr 24–48 hr 2–6 days
Overall n (of
19) % n (of 7) % n (of 80) %
S. aureus 6 2 5 13 68.4 3 42.9 16 20
E. coli 1 2 0 3 15.8 1 14.3 4 5
Klebsiella sp. 1 0 0 1 5.3 1 14.3 2 2.5
unidentified coliform 1 0 0 1 5.3 2 28.6 3 3.8
Group B Streptococcus 1 0 0 1 5.3 0 0 1 1.3
Total 10 4 5 19 7 26 32.5
doi:10.1371/journal.pone.0072775.t001
Table 2. Vaginal culture summary.
n (of 53) %
Klebsiella sp. 10 18.9
S. aureus 7 13.2
E. coli 6 9.4
C. albicans 2 3.8
Strep sp. 1 1.9
unidentified coliform 1 1.9
doi:10.1371/journal.pone.0072775.t002
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difference in sample volumes, it does not appear to be substantial
in that both series fail to recover culturable organisms in a
comparable majority of cases of clinical NS.
Another factor reducing the rate of organism recovery is the
inconsistent and largely undocumented administration of anti-
biotics to 38.7% of these neonates prior to arrival at the Mbarara
Regional Hospital. Of this cohort, failure of organism recovery
through culture was 77% (24 of 31). Such partial treatment of
active infection should disproportionately reduce the organism
recovery rate by culture, with less effect on identification through
molecular approaches. However, in our cohort, the rate of
recovery of culturable organisms was not significantly different in
the infants who received antibiotics.
We designed our inclusion criteria to maximize the inclusion of
neonates with true microbial sepsis, but we recognize that some of
these infants will suffer from noninfectious syndromes such as
hypoxic-ischemic encephalopathy. We anticipate that the fraction
of false positive diagnoses of microbial sepsis is low in our sampled
population, but we remain unable to quantitatively estimate the
true fraction of uninfected neonates in this cohort.
Our blood culture findings were dominated by S. aureus, E. Coli,
and Klebsiella species, organisms that have been described in
different combinations as major causes of NS in developing
countries [1]. Our particular combination is very similar to the
spectrum of organisms recovered from neonatal blood in the
Mulago Hospital series in Uganda [17]. With the exception of the
occasional report (such as the large series from Malawi [8,11]), in
many settings of infants with NS in developing countries the
recovery of group B Streptococci appears unusual [17]. It remains
unclear why rates of group B streptococcal sepsis are more
uniformly prominent in sepsis in the first week of life in industrial
countries [24]. In parallel with sepsis rates, the maternal carriage
rates of group B Streptococci can differ in developing and
industrialized countries and can vary at different sites [11]. In
our series, we recovered only 1 case of group B Streptococcus on
blood culture, and recovered Streptococcal species from only one
vaginal culture. Our findings are consistent with a low rate of
group B Streptococcal NS correlating with a low rate of maternal
vaginal carriage in this southwestern Ugandan population.
It is of concern that births in hospitals in the developing world
may be settings for acquisition of S. aureus and K. pneumoniae
infections from hygiene practices and common source infections
[25]. Although in principle we may be able in the future to validate
maternal transmission from genetic fingerprinting of bacteria
found in both mother and infant, we are presently unable to
distinguish between maternal and caregiver sources. In addition,
the vast majority of births in Uganda are out of hospital, where
hygiene practices will carry infection risks quite distinct from those
documented within hospital settings [25]. Our findings of
discordant culture results in early sepsis between infants and
maternal cultures are consistent with a contribution from non-
maternal peripartum hygiene effects.
To our knowledge, this is the first study of NS in a developing
country where an attempt has been made to correlate infant blood
and CSF organisms with maternal vaginal flora to ascertain the
role of maternal transmission at birth to NS. Although a broadly
similar range of organisms was recovered from infants’ blood and




48 hr 2–6 days n (% of 19) n (% of 7) n (% of 80)
S. aureus 0 0 0 0 0 1 14.3 1 1.25
E. coli 2 0 0 2 10.5 1 14.3 3 3.75
Klebsiella sp. 1 0 0 1 5.3 0 0 1 1.25
unidentified coliform 0 0 0 0 0 0 0 0 0
Streptococcus spp. 0 0 1 1 5.3 0 0 1 1.25
No bacterial growth 3 3 2 8 42.1 5 71.4 13 16.25
No consent for swab 3 1 2 6 31.6 1 14.3 7 8.75
Not done 1 0 0 1 5.3 0 0 1 1.25
Total 10 4 5 19 7 26* 32.5*
*One mother had a mixed growth of E. coli and Staphylococcus aureus, and the totals are adjusted for this.
doi:10.1371/journal.pone.0072775.t003
Table 4. Comparison between maternal and infants’ organisms.
Patient ID Mother’s vaginal swab culture Infant’s blood culture Infant’s CSF culture
1 NS008 E. coli S. aureus No growth
2 NS012 E. coli S. aureus No growth
3 NS019 Mixed growth - E. coli/S. aureus Unidentified coliform No growth
4 NS026 Klebsiella S. aureus No growth
5 NS035 Streptococcus sp. S. aureus No growth
Table represents patients in whom a potential pathogen was recovered from both the infant and the mother.
doi:10.1371/journal.pone.0072775.t004
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organisms recovered from blood and vaginal cultures in the same
mother-infant pairs. Culture data is biased towards organisms that
grow most readily in the available culture media, and this
undoubtedly contributes to the similar spectrum of organisms
recovered.
The EOS patients had a higher predominance of S. aureus than
LOS patients (68.4 vs 42.9%). S. aureus was one of the more
common pathogens recovered from maternal vaginal sampling
(13%), and although not concordant, neither are our findings
inconsistent with a maternal source of this agent for EOS cases. It
is also possible that maternal flora changes substantially in the days
following birth, progressively obscuring the source of causative
pathogens with delayed vaginal bacterial culture. Nevertheless, we
anticipate, especially in the EOS cases (.80% of our cases), that it
should be possible to recover genomic sequences remaining from
pathogens that may have been transmitted to the infant during
birth. The time-scale beyond which such evidence of maternal
carriage becomes undetectable, with culture and molecular
techniques, is presently unknown.
In the present study, we found only two cases with evidence of
meningitis, and both patients had negative blood cultures. The
treatment of NS involving meningitis should be significantly more
prolonged than for NS that does not involve the nervous system
[2]. Nevertheless, performing lumbar puncture in developing
world settings adds to the complexity and expense of evaluating
infants with NS. Our finding of negative blood cultures in the
presence of culture-positive neonatal meningitis further empha-
sizes the potential unreliability of blood culture as a screening tool
for infection in the CSF in NS, and the potential value of routine
lumbar puncture in such settings.
In related work, we have identified a population of infants
surviving NS in Uganda who develop postinfectious hydrocepha-
lus (PIH) [26]. These infants often demonstrate a significant degree
of brain destruction as a consequence of prior NS, and typically
give a history of convulsions during the previous septic episode
[26]. Although we have been unsuccessful in recovering organisms
from the CSF of such infants with PIH using bacterial culture,
sequencing the 16S ribosomal DNA from the CSF reveals a
predominance of sequences from Gram-negative bacteria, espe-
cially Acinetobacter, Klebsiella, and E. coli species [13]. Consistent with
the present study based on bacterial culture, it was uncommon to
detect DNA fragments from streptococcal species in PIH infants in
Uganda [13]. A recently confirmed link between rainfall climate
dynamics and NS cases leading to PIH [27], supports an
environmental source for an important fraction of PIH cases. A
long-term survival analysis [28] and an economic burden of
disease analysis [29] demonstrate the severe consequences for this
cohort of survivors of NS. Nevertheless, this present NS study does
not further identify the agents responsible for these post-sepsis
hydrocephalic sequelae.
Neonatal sepsis is a serious disorder where there is substantial
morbidity in the survivors. The optimal approach to these infants
is prevention. Prevention requires that we identify the routes of
infection, and either institute appropriate antimicrobial prophy-
laxis if maternally transmitted at birth, or create public health
interventions if infections occur in the infants’ home environments.
Properly assessing the causes of NS will require that we identify the
putative causal agents responsible for this disorder.
Conclusions
Our findings, and the literature of NS from the developing
world, suggest that traditional bacterial culture techniques may be
failing to identify a substantial fraction of the causal agents of
neonatal sepsis. Furthermore, bacterial culture appears unable to
suitably delineate the roles of maternal versus environmental
sources of infection in this setting. Alternative molecular
technologies may therefore have a valuable role to play in
characterizing the microbial spectra associated with neonatal
sepsis [30], which will be a prerequisite for better treatment and
prevention of these infections.
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